Epileptic seizures at multiple sclerosis onset and their role in disease progression.

epidemiology epilepsy multiple sclerosis

Journal

Therapeutic advances in neurological disorders
ISSN: 1756-2856
Titre abrégé: Ther Adv Neurol Disord
Pays: England
ID NLM: 101480242

Informations de publication

Date de publication:
2023
Historique:
received: 19 12 2022
accepted: 20 07 2023
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

Epileptic seizures can occur throughout the course of multiple sclerosis (MS) and are associated with increasing disability progression over time. However, there are no data on whether epileptic seizures at the onset of MS also lead to increasing disability. To examine disease progression over time for MS patients with epileptic seizures at onset. We analyzed the data of 30,713 patients on the German Multiple Sclerosis Register in a case-control study for more than 15 years. MS patients with seizures at onset were further divided into subgroups with polysymptomatic and monosymptomatic onset to assess the impact of additional symptoms on disease progression. A total of 46 patients had seizures as onset symptoms. Expanded Disability Status Scale (EDSS) within the first year was lower in the group with seizures at onset compared to controls (0.75 Epileptic seizures at MS onset are associated with a higher amount of disability progression over time. Additional longitudinal data are needed to further clarify the impact of seizures on the pathophysiology of MS disease progression.

Sections du résumé

Background UNASSIGNED
Epileptic seizures can occur throughout the course of multiple sclerosis (MS) and are associated with increasing disability progression over time. However, there are no data on whether epileptic seizures at the onset of MS also lead to increasing disability.
Objective UNASSIGNED
To examine disease progression over time for MS patients with epileptic seizures at onset.
Methods UNASSIGNED
We analyzed the data of 30,713 patients on the German Multiple Sclerosis Register in a case-control study for more than 15 years. MS patients with seizures at onset were further divided into subgroups with polysymptomatic and monosymptomatic onset to assess the impact of additional symptoms on disease progression.
Results UNASSIGNED
A total of 46 patients had seizures as onset symptoms. Expanded Disability Status Scale (EDSS) within the first year was lower in the group with seizures at onset compared to controls (0.75
Conclusion UNASSIGNED
Epileptic seizures at MS onset are associated with a higher amount of disability progression over time. Additional longitudinal data are needed to further clarify the impact of seizures on the pathophysiology of MS disease progression.

Identifiants

pubmed: 37808247
doi: 10.1177/17562864231192826
pii: 10.1177_17562864231192826
pmc: PMC10559692
doi:

Types de publication

Journal Article

Langues

eng

Pagination

17562864231192826

Informations de copyright

© The Author(s), 2023.

Références

Mult Scler. 2017 Mar;23(3):473-482
pubmed: 27260699
Mult Scler. 2022 May;28(6):942-949
pubmed: 34595974
Mult Scler. 2016 Feb;22(2):250-3
pubmed: 26084350
Eur J Neurol. 2022 Dec;29(12):3537-3546
pubmed: 36083790
J Neurol Neurosurg Psychiatry. 2012 Jan;83(1):49-54
pubmed: 21890577
Mult Scler. 2015 Mar;21(3):342-9
pubmed: 25533301
Neurol Sci. 2017 Mar;38(3):399-406
pubmed: 28054170
Seizure. 2017 Nov;52:131-135
pubmed: 29031194
Mult Scler. 2019 Oct;25(12):1641-1652
pubmed: 30230952
Sci Rep. 2021 Jun 25;11(1):13340
pubmed: 34172792
Nervenarzt. 2005 Aug;76(8):967-75
pubmed: 15806419
Mult Scler. 2011 Jan;17(1):96-102
pubmed: 20861180
Neurology. 2017 Dec 12;89(24):2462-2468
pubmed: 29117950
BMC Neurol. 2014 Mar 25;14:58
pubmed: 24666846
Mult Scler Relat Disord. 2020 Feb;38:101497
pubmed: 31726355
Brain. 2000 May;123 ( Pt 5):1027-40
pubmed: 10775547
Neuroscientist. 2012 Aug;18(4):360-72
pubmed: 22235060
Mult Scler Relat Disord. 2020 Nov;46:102485
pubmed: 32980646
J Neurol. 2021 May;268(5):1721-1727
pubmed: 33324995

Auteurs

Matthias Grothe (M)

Department of Neurology, University Medicine Greifswald, Ferdinand-Sauerbruchstraße, Greifswald 17475, Germany.

David Ellenberger (D)

German MS Register by the German MS Society, MS Research and Project Development gGmbH [MSFP], Hanover, Germany.

Paulus S Rommer (PS)

Department of Neurology, Medical University of Vienna, Vienna, Austria.
Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.

Alexander Stahmann (A)

German MS Register by the German MS Society, MS Research and Project Development gGmbH [MSFP], Hanover, Germany.

Uwe K Zettl (UK)

Department of Neurology, Neuroimmunological Section, University of Rostock, Rostock, Germany.

Classifications MeSH